Kenzen (Seed+)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$40,080,001
Company Info
Founders
Kyle Hubregtse
Market
Healthcare & Wellness
Coinvestors
Mars Health Fund,Manifold,Royal Street Ventures
Company Description

Using sweat analysis & continuous health monitoring to help you get ahead of injuries & avoidable health conditions. Kenzen’s Mission is to harness the power of physiology data to predict and prevent industrial workforce injuries and improve productivity.